No announcement yet.

Faster Cures: Priming The Pump: Filling the Therapeutic Pipeline

  • Filter
  • Time
  • Show
Clear All
new posts

  • Faster Cures: Priming The Pump: Filling the Therapeutic Pipeline

    There is almost universal concern in the biomedical research enterprise about the declining productivity of the system. While there seems to be no shortage of scientific opportunity, there are precious few new products reaching the market, and even fewer genuine breakthroughs. Is innovative science enough these days, or are there management and financial innovations that need to go hand-in-hand? What are some of the novel ways companies are seeking to share risk with other stakeholders, from the government to universities to nonprofit organizations? How are these partnerships affecting industry's priorities and decision-making?
    Jeffrey Brewer, President and CEO, Juvenile Diabetes Research Foundation
    Susan Desmond-Hellmann, M.D., MPH , Chancellor, University of California, San Francisco
    Margaret A. Hamburg, M.D. , Commissioner, U.S. Food and Drug Administration
    John Mendlein, Ph.D., J.D., Executive Chairman, Fate Therapeutics and Chairman, aTyr Pharma
    Garry Neil, M.D., Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson
    Last edited by GRAMMY; 03-22-2012, 12:54 PM.

  • #2
    Sounds very interesting.
    I see a list of speakers and the topic, but I don't see any dates or times.
    Are you just teasing us
    Dennis Tesolat

    "Change does not roll in on the wheels of inevitability, but comes through continuous struggle. And so we must straighten our backs and work for our freedom."
    Martin Luther King